Psychology and Neuroscience Faculty Database
Psychology and Neuroscience
Arts & Sciences
Duke University

 HOME > Arts & Sciences > pn > Faculty    Search Help Login pdf version printable version 

Publications of Scott H. Kollins    :chronological  alphabetical  combined  bibtex listing:

search PubMed.

Journal Articles

  1. Sanchez, CE; Barry, C; Sabhlok, A; Russell, K; Majors, A; Kollins, SH; Fuemmeler, BF (2018). Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis.. Obesity Reviews, 19(4), 464-484. [doi]  [abs]
  2. Lee, C-T; McClernon, FJ; Kollins, SH; Fuemmeler, BF (2018). Childhood ADHD Symptoms and Future Illicit Drug Use: The Role of Adolescent Cigarette Use.. Journal of Pediatric Psychology, 43(2), 162-171. [doi]  [abs]
  3. Sweitzer, MM; Kollins, SH; Kozink, RV; Hallyburton, M; English, J; Addicott, MA; Oliver, JA; McClernon, FJ (2018). ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.. Neuropsychopharmacology (Nature), 43(4), 851-858. [doi]  [abs]
  4. Davis, NO; Bower, J; Kollins, SH (2018). Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD.. PloS one, 13(1), e0189749. [doi]  [abs]
  5. Schechter, JC; Fuemmeler, BF; Hoyo, C; Murphy, SK; Zhang, JJ; Kollins, SH (2018). Impact of Smoking Ban on Passive Smoke Exposure in Pregnant Non-Smokers in the Southeastern United States.. International journal of environmental research and public health, 15(1). [doi]  [abs]
  6. Mitchell, JT; McIntyre, EM; English, JS; Dennis, MF; Beckham, JC; Kollins, SH (2017). A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation.. Journal of Attention Disorders, 21(13), 1105-1120. [24305060], [doi]  [abs]
  7. McCullough, LE; Miller, EE; Calderwood, LE; Shivappa, N; Steck, SE; Forman, MR; A Mendez, M; Maguire, R; Fuemmeler, BF; Kollins, SH; D Bilbo, S; Huang, Z; Murtha, AP; Murphy, SK; Hébert, JR; Hoyo, C (2017). Maternal inflammatory diet and adverse pregnancy outcomes: Circulating cytokines and genomic imprinting as potential regulators?. Epigenetics : official journal of the DNA Methylation Society, 12(8), 688-697. [doi]  [abs]
  8. Schechter, JC; Kollins, SH (2017). Prenatal Smoke Exposure and ADHD: Advancing the Field.. Pediatrics, 139(2). [doi]
  9. Childress, AC; Kollins, SH; Cutler, AJ; Marraffino, A; Sikes, CR (2017). Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.. Journal of Child and Adolescent Psychopharmacology, 27(1), 66-74. [doi]  [abs]
  10. Mitchell, JT; Weisner, TS; Jensen, PS; Murray, DW; Molina, BSG; Arnold, EL; Hechtman, L; Swanson, JM; Hinshaw, SP; Victor, EC; Kollins, SH; Wells, KC; Belendiuk, KA; Blonde, A; Nguyen, C; Ambriz, L; Nguyen, JL (2017). How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning.. Journal of Attention Disorders, 1087054716685842. [doi]  [abs]
  11. Lunsford-Avery, JR; Krystal, AD; Kollins, SH (2016). Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research.. Clinical Psychology Review, 50, 159-174. [doi]  [abs]
  12. Schoenfelder, EN; Kollins, SH (2016). Topical Review: ADHD and Health-Risk Behaviors: Toward Prevention and Health Promotion.. Journal of Pediatric Psychology, 41(7), 735-740. [doi]  [abs]
  13. Mitchell, JT; Sweitzer, MM; Tunno, AM; Kollins, SH; McClernon, FJ (2016). "I Use Weed for My ADHD": A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD.. PloS one, 11(5), e0156614. [doi]  [abs]
  14. Faraone, SV; Childress, A; Wigal, SB; Kollins, SH; McDonnell, MA; DeSousa, NJ; Sallee, FR (2015). Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised.. Journal of Attention Disorders. [doi]  [abs]
  15. Koblan, KS; Hopkins, SC; Sarma, K; Jin, F; Goldman, R; Kollins, SH; Loebel, A (2015). Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.. Neuropsychopharmacology (Nature), 40(12), 2745-2752. [doi]  [abs]
  16. Vitiello, B; Lazzaretto, D; Yershova, K; Abikoff, H; Paykina, N; McCracken, JT; McGough, JJ; Kollins, SH; Greenhill, LL; Wigal, S; Wigal, T; Riddle, MA (2015). Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up.. Journal of the American Academy of Child and Adolescent Psychiatry, 54(7), 550-556. [doi]  [abs]
  17. Childress, AC; Brams, M; Cutler, AJ; Kollins, SH; Northcutt, J; Padilla, A; Turnbow, JM (2015). The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.. Journal of Child and Adolescent Psychopharmacology, 25(5), 402-414. [doi]  [abs]
  18. Mitchell, JT; Zylowska, L; Kollins, SH (2015). Mindfulness Meditation Training for Attention-Deficit/Hyperactivity Disorder in Adulthood: Current Empirical Support, Treatment Overview, and Future Directions.. Cognitive and Behavioral Practice, 22(2), 172-191. [doi]  [abs]
  19. Fuemmeler, BF; Hoyo, C; Murphy, S; Vidal, AC; Kollins, SH (2015). PRE-PREGNANCY OBESITY AND OFFSPRING NEUROBEHAVIORAL DEVELOPMENT. Annals of Behavioral Medicine, 49, S252-S252. [Gateway.cgi]
  20. Lee, C-T; Clark, TT; Kollins, SH; McClernon, FJ; Fuemmeler, BF (2015). Attention Deficit Hyperactivity Disorder symptoms and smoking trajectories: race and gender differences.. Drug and Alcohol Dependence, 148, 180-187. [doi]  [abs]
  21. Lee, CT; Clark, TT; Kollins, SH; McClernon, JF; Fuemmeler, BF (2015). Attention Deficit Hyperactivity Disorder symptoms and smoking trajectories: Race and gender differences. Drug and Alcohol Dependence, 148, 180-187. [doi]  [abs]
  22. Kollins, SH; Schoenfelder, EN; English, JS; Holdaway, A; Van Voorhees, E; O'Brien, BR; Dew, R; Chrisman, AK (2015). An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults. Journal of Substance Abuse Treatment, 48(1), 96-103. [doi]  [abs]
  23. Kollins, SH; Schoenfelder, EN; English, JS; Holdaway, A; Van Voorhees, E; O'Brien, BR; Dew, R; Chrisman, AK (2015). An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.. Journal of Substance Abuse Treatment, 48(1), 96-103. [doi]  [abs]
  24. Koblan, KS; Hopkins, SC; Sarma, K; Jin, F; Goldman, R; Kollins, SH; Loebel, A (2015). Dasotraline for the treatment of attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled, proof-of-concept trial in adults. Neuropsychopharmacology (Nature), 40(12), 2745-2752. [doi]  [abs]
  25. Wigal, SB; Greenhill, LL; Nordbrock, E; Connor, DF; Kollins, SH; Adjei, A; Childress, A; Stehli, A; Kupper, RJ (2014). A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.. Journal of Child and Adolescent Psychopharmacology, 24(10), 562-569. [doi]  [abs]
  26. Smith, TF; Anastopoulos, AD; Garrett, ME; Arias-Vasquez, A; Franke, B; Oades, RD; Sonuga-Barke, E; Asherson, P; Gill, M; Buitelaar, JK; Sergeant, JA; Kollins, SH; Faraone, SV; Ashley-Koch, A; IMAGE Consortium, (2014). Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity.. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 165B(8), 691-704. [doi]  [abs]
  27. Adjei, A; Kupper, RJ; Teuscher, NS; Wigal, S; Sallee, F; Childress, A; Kollins, SH; Greenhill, L (2014). Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.. Clinical drug investigation, 34(11), 795-805. [doi]  [abs]
  28. Mitchell, JT; Dennis, MF; English, JS; Dennis, PA; Brightwood, A; Beckham, JC; Kollins, SH (2014). Ecological momentary assessment of antecedents and consequences of smoking in adults with attention-deficit/hyperactivity disorder.. Substance Use & Misuse (Informa), 49(11), 1446-1456. [doi]  [abs]
  29. Kollins, SH; Adcock, RA (2014). ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: Implications for smoking and nicotine dependence. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 52, 70-78. [doi]  [abs]
  30. Kollins, SH; Adcock, RA (2014). ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 52, 70-78. [doi]  [abs]
  31. Schoenfelder, EN; Faraone, SV; Kollins, SH (2014). Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.. Pediatrics, 133(6), 1070-1080. [doi]  [abs]
  32. Kollins, SH; English, JS; Itchon-Ramos, N; Chrisman, AK; Dew, R; O'Brien, B; McClernon, FJ (2014). A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD.. Journal of Attention Disorders, 18(2), 158-168. [22508760], [doi]  [abs]
  33. Mitchell, JT; Schick, RS; Hallyburton, M; Dennis, MF; Kollins, SH; Beckham, JC; McClernon, FJ (2014). Combined ecological momentary assessment and global positioning system tracking to assess smoking behavior: a proof of concept study.. Journal of Dual Diagnosis, 10(1), 19-29. [doi]  [abs]
  34. Mitchell, JT; McIntyre, EM; McClernon, FJ; Kollins, SH (2014). Smoking motivation in adults with attention-deficit/hyperactivity disorder using the Wisconsin inventory of smoking dependence motives.. Nicotine and Tobacco Research (OUP), 16(1), 120-125. [24078759], [doi]  [abs]
  35. Adjei, A; Kupper, RJ; Teuscher, NS; Wigal, S; Sallee, F; Childress, A; Kollins, SH; Greenhill, L (2014). Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers. Clinical drug investigation, 34(11), 795-805. [doi]  [abs]
  36. Weisler, RH; Adler, LA; Kollins, SH; Goodman, DW; Hamdani, M; Dirks, B; Childress, AC (2014). Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate.. Neuropsychiatric disease and treatment, 10, 1-12. [24363557], [doi]  [abs]
  37. Lee, C-T; Fuemmeler, BF; McClernon, FJ; Ashley-Koch, A; Kollins, SH (2013). Nicotinic receptor gene variants interact with attention deficient hyperactive disorder symptoms to predict smoking trajectories from early adolescence to adulthood.. Addictive Behaviors, 38(11), 2683-2689. [23899432], [doi]  [abs]
  38. Lee, C-T; McClernon, FJ; Kollins, SH; Prybol, K; Fuemmeler, BF (2013). Childhood economic strains in predicting substance use in emerging adulthood: mediation effects of youth self-control and parenting practices.. Journal of Pediatric Psychology, 38(10), 1130-1143. [23899658], [doi]  [abs]
  39. Kollins, SH; Schoenfelder, E; English, JS; McClernon, FJ; Dew, RE; Lane, SD (2013). Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).. Experimental and Clinical Psychopharmacology, 21(5), 375-384. [24099358], [doi]  [abs]
  40. Fuemmeler, B; Lee, C-T; Ranby, KW; Clark, T; McClernon, FJ; Yang, C; Kollins, SH (2013). Individual- and community-level correlates of cigarette-smoking trajectories from age 13 to 32 in a U.S. population-based sample.. Drug and Alcohol Dependence, 132(1-2), 301-308. [23499056], [doi]  [abs]
  41. Kollins, SH; English, JS; Roley, ME; O'Brien, B; Blair, J; Lane, SD; McClernon, FJ (2013). Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.. Psychopharmacology, 227(1), 19-30. [23247366], [doi]  [abs]
  42. Riddle, MA; Yershova, K; Lazzaretto, D; Paykina, N; Yenokyan, G; Greenhill, L; Abikoff, H; Vitiello, B; Wigal, T; McCracken, JT; Kollins, SH; Murray, DW; Wigal, S; Kastelic, E; McGough, JJ; dosReis, S; Bauzó-Rosario, A; Stehli, A; Posner, K (2013). The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.. Journal of the American Academy of Child and Adolescent Psychiatry, 52(3), 264-278.e2. [23452683], [doi]  [abs]
  43. Fuemmeler, B; Lee, C-T; Ranby, KW; Clark, T; McClernon, FJ; Yang, C; Kollins, SH (2013). Individual- and community-level correlates of cigarette-smoking trajectories from age 13 to 32 in a U.S. population-based sample. Drug and Alcohol Dependence, 132(1-2), 301-308. [doi]  [abs]
  44. Wang, G-J; Volkow, ND; Wigal, T; Kollins, SH; Newcorn, JH; Telang, F; Logan, J; Jayne, M; Wong, CT; Han, H; Fowler, JS; Zhu, W; Swanson, JM (2013). Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.. PloS one, 8(5), e63023. [23696790], [doi]  [abs]
  45. Kollins, SH; English, JS; Roley, ME; O'Brien, B; Blair, J; Lane, SD; McClernon, FJ (2013). Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder. Psychopharmacology, 227(1), 19-30. [doi]  [abs]
  46. Mitchell, JT; Van Voorhees, EE; Dennis, MF; McClernon, FJ; Calhoun, PS; Kollins, SH; Beckham, JC (2012). Assessing the role of attention-deficit/hyperactivity disorder symptoms in smokers with and without posttraumatic stress disorder.. Nicotine and Tobacco Research (OUP), 14(8), 986-992. [22180583], [doi]  [abs]
  47. Davis, NO; Kollins, SH (2012). Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder.. Neurotherapeutics, 9(3), 518-530. [22678458], [doi]  [abs]
  48. Sallee, FR; Kollins, SH; Wigal, TL (2012). Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder.. Journal of Child and Adolescent Psychopharmacology, 22(3), 206-214. [22612526], [doi]  [abs]
  49. Van Voorhees, EE; Mitchell, JT; McClernon, FJ; Beckham, JC; Kollins, SH (2012). Sex, ADHD symptoms, and smoking outcomes: an integrative model.. Medical Hypotheses, 78(5), 585-593. [22341778], [doi]  [abs]
  50. Bidwell, LC; Garrett, ME; McClernon, FJ; Fuemmeler, BF; Williams, RB; Ashley-Koch, AE; Kollins, SH (2012). A preliminary analysis of interactions between genotype, retrospective ADHD symptoms, and initial reactions to smoking in a sample of young adults.. Nicotine and Tobacco Research (OUP), 14(2), 229-233. [21778150], [doi]  [abs]
  51. Faraone, SV; Spencer, TJ; Kollins, SH; Glatt, SJ; Goodman, D (2012). Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory study.. Journal of Attention Disorders, 16(2), 118-127. [21527575], [doi]  [abs]
  52. Volkow, ND; Wang, G-J; Tomasi, D; Kollins, SH; Wigal, TL; Newcorn, JH; Telang, FW; Fowler, JS; Logan, J; Wong, CT; Swanson, JM (2012). Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 32(3), 841-849. [22262882], [doi]  [abs]
  53. Mitchell, JT; Robertson, CD; Anastopolous, AD; Nelson-Gray, RO; Kollins, SH (2012). Emotion dysregulation and emotional impulsivity among adults with attention-deficit/hyperactivity disorder: Results of a preliminary study. Journal of Psychopathology and Behavioral Assessment, 34(4), 510-519. [doi]  [abs]
  54. Mitchell, JT; Robertson, CD; Anastopolous, AD; Nelson-Gray, RO; Kollins, SH (2012). Emotion Dysregulation and Emotional Impulsivity among Adults with Attention-Deficit/Hyperactivity Disorder: Results of a Preliminary Study. Journal of Psychopathology and Behavioral Assessment, 1-10. [doi]  [abs]
  55. Ranby, KW; Boynton, MH; Kollins, SH; McClernon, FJ; Yang, C; Fuemmeler, BF (2012). Understanding the phenotypic structure of adult retrospective ADHD symptoms during childhood in the United States.. Journal of Clinical Child & Adolescent Psychology, 41(3), 261-274. [22394329], [doi]  [abs]
  56. Voorhees, EV; McClernon, FJ; Fuemmeler, B; English, J; Holdaway, A; Hallyburton, M; Dew, R; Kollins, S (2012). An examination of differences in variables maintaining smoking behavior in adult smokers with and without attention-deficit/hyperactivity disorder. Addiction Research & Theory (Informa), 20(1), 72-81. [doi]  [abs]
  57. Volkow, ND; Wang, G-J; Newcorn, JH; Kollins, SH; Wigal, TL; Telang, F; Fowler, JS; Goldstein, RZ; Klein, N; Logan, J; Wong, C; Swanson, JM (2011). Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.. Molecular Psychiatry, 16(11), 1147-1154. [20856250], [doi]  [abs]
  58. Anastopoulos, AD; Smith, TF; Garrett, ME; Morrissey-Kane, E; Schatz, NK; Sommer, JL; Kollins, SH; Ashley-Koch, A (2011). Self-Regulation of Emotion, Functional Impairment, and Comorbidity Among ChildrenWith AD/HD.. Journal of Attention Disorders, 15(7), 583-592. [20686097], [doi]  [abs]
  59. McClernon, FJ; Van Voorhees, EE; English, J; Hallyburton, M; Holdaway, A; Kollins, SH (2011). Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial.. Nicotine and Tobacco Research (OUP), 13(9), 784-792. [21571687], [doi]  [abs]
  60. Bidwell, LC; McClernon, FJ; Kollins, SH (2011). Cognitive enhancers for the treatment of ADHD.. Pharmacology, Biochemistry and Behavior, 99(2), 262-274. [21596055], [doi]  [abs]
  61. Kollins, SH; Jain, R; Brams, M; Segal, S; Findling, RL; Wigal, SB; Khayrallah, M (2011). Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.. Pediatrics, 127(6), e1406-e1413. [21555501], [doi]  [abs]
  62. Fuemmeler, BF; Østbye, T; Yang, C; McClernon, FJ; Kollins, SH (2011). Association between attention-deficit/hyperactivity disorder symptoms and obesity and hypertension in early adulthood: a population-based study.. International Journal of Obesity, 35(6), 852-862. [20975727], [doi]  [abs]
  63. Kratochvil, CJ; Vaughan, BS; Stoner, JA; Daughton, JM; Lubberstedt, BD; Murray, DW; Chrisman, AK; Faircloth, MA; Itchon-Ramos, NB; Kollins, SH; Maayan, LA; Greenhill, LL; Kotler, LA; Fried, J; March, JS (2011). A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.. Pediatrics, 127(4), e862-e868. [21422081], [doi]  [abs]
  64. Kollins, SH; López, FA; Vince, BD; Turnbow, JM; Farrand, K; Lyne, A; Wigal, SB; Roth, T (2011). Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder.. Journal of Child and Adolescent Psychopharmacology, 21(2), 111-120. [21476931], [doi]  [abs]
  65. Van Voorhees, EE; Hardy, KK; Kollins, SH (2011). Reliability and validity of self- and other-ratings of symptoms of ADHD in adults.. Journal of Attention Disorders, 15(3), 224-234. [20424007], [doi]  [abs]
  66. Rizzi, TS; Arias-Vasquez, A; Rommelse, N; Kuntsi, J; Anney, R; Asherson, P; Buitelaar, J; Banaschewski, T; Ebstein, R; Ruano, D; Van der Sluis, S; Markunas, CA; Garrett, ME; Ashley-Koch, AE; Kollins, SH; Anastopoulos, AD; Hansell, NK; Wright, MJ; Montgomery, GW; Martin, NG; Harris, SE; Davies, G; Tenesa, A; Porteous, DJ; Starr, JM; Deary, IJ; St Pourcain, B; Davey Smith, G; Timpson, NJ; Evans, DM; Gill, M; Miranda, A; Mulas, F; Oades, RD; Roeyers, H; Rothenberger, A; Sergeant, J et al. (2011). The ATXN1 and TRIM31 genes are related to intelligence in an ADHD background: evidence from a large collaborative study totaling 4,963 subjects.. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 156(2), 145-157. [21302343], [doi]  [abs]
  67. Jain, R; Segal, S; Kollins, SH; Khayrallah, M (2011). Clonidine Extended-Release Tablets for Pediatric Patients With Attention-Deficit/Hyperactivity Disorder (vol 50, pg 171, 2011). Journal of the American Academy of Child and Adolescent Psychiatry, 50(3), 313-313. [Gateway.cgi], [doi]
  68. Bidwell, LC; Dew, RE; Kollins, SH (2011). Erratum: alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.. Current Psychiatry Reports, 13(1), 76. [21136308], [doi]
  69. Kollins, SH; Youcha, S; Lasser, R; Thase, ME (2011). Lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder in adults with a history of depression or history of substance use disorder.. Innovations in Clinical Neuroscience, 8(2), 28-32. [21468295]  [abs]
  70. Jain, R; Segal, S; Kollins, SH; Khayrallah, M (2011). Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.. Journal of the American Academy of Child and Adolescent Psychiatry, 50(2), 171-179. [21241954], [doi]  [abs]
  71. TS Rizzi, A Arias-Vasquez, N Rommelse, J Kuntsi, R Anney, P Asherson, J Buitelaar, T Banaschewski, R Ebstein, D Ruano, S Van der Sluis, CA Markunas, ME Garrett, AE Ashley-Koch, SH Kollins, AD Anastopoulos, NK Hansell, MJ Wright, GW Montgomery, NG Martin, SE Harris, G Davies, A Tenesa, DJ Porteous, JM Starr, IJ Deary, B St Pourcain, GD Smith, NJ Timpson, DM Evans, M Gill, A Miranda, F Mulas, RD Oades, H Roeyers, A Rothenberger, J Sergeant, E Sonuga-Barke, HC Steinhausen, E Taylor, SV Faraone, B Franke, D Posthuma (2010). The ATXN1 and TRIM31 Genes Are Related to Intelligence in an ADHD Background: Evidence From a Large Collaborative Study Totaling 4,963 Subjects.. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. [doi]  [abs]
  72. Wigal, SB; Kollins, SH; Childress, AC; Adeyi, B (2010). Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day.. Child and Adolescent Psychiatry and Mental Health, 4, 32. [21156071], [doi]  [abs]
  73. Dew, RE; Kollins, SH (2010). Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD.. Expert Opinion on Pharmacotherapy, 11(17), 2907-2913. [20979573], [doi]  [abs]
  74. Kozink, RV; Kollins, SH; McClernon, FJ (2010). Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control.. Neuropsychopharmacology, 35(13), 2600-2606. [20861830], [doi]  [abs]
  75. Cinnamon Bidwell, L; Dew, RE; Kollins, SH (2010). Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.. Current Psychiatry Reports, 12(5), 366-373. [20652773], [doi]  [abs]
  76. Connor, DF; Findling, RL; Kollins, SH; Sallee, F; López, FA; Lyne, A; Tremblay, G (2010). Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.. CNS Drugs, 24(9), 755-768. [20806988], [doi]  [abs]
  77. AD Anastopoulos, TF Smith, ME Garrett, E Morrissey-Kane, NK Schatz, JL Sommer, SH Kollins, A Ashley-Koch (2010). Self-Regulation of Emotion, Functional Impairment, and Comorbidity Among Children With ADHD.. Journal of attention disorders. [doi]  [abs]
  78. Kollins, SH; McClernon, FJ; Van Voorhees, EE (2010). Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD).. Experimental and Clinical Psychopharmacology, 18(3), 221-228. [20545386], [doi]  [abs]
  79. Kollins, S (2010). Subjective Effects of Methylphenidate. [doi]  [abs]
  80. Markunas, CA; Quinn, KS; Collins, AL; Garrett, ME; Lachiewicz, AM; Sommer, JL; Morrissey-Kane, E; Kollins, SH; Anastopoulos, AD; Ashley-Koch, AE (2010). Genetic variants in SLC9A9 are associated with measures of attention-deficit/hyperactivity disorder symptoms in families.. Psychiatric Genetics, 20(2), 73-81. [20032819], [doi]  [abs]
  81. Polanczyk, G; Caspi, A; Houts, R; Kollins, SH; Rohde, LA; Moffitt, TE (2010). Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort.. Journal of the American Academy of Child and Adolescent Psychiatry, 49(3), 210-216. [20410710]  [abs]
  82. Faraone, SV; Spencer, TJ; Kollins, SH; Glatt, SJ (2010). Effects of lisdexamfetamine dimesylate treatment for ADHD on growth.. Journal of the American Academy of Child and Adolescent Psychiatry, 49(1), 24-32. [20215923]  [abs]
  83. Volkow, ND; Wang, G-J; Kollins, SH; Wigal, TL; Newcorn, JH; Telang, F; Fowler, JS; Zhu, W; Logan, J; Ma, Y; Pradhan, K; Wong, C; Swanson, JM (2009). Evaluating dopamine reward pathway in ADHD: clinical implications.. JAMA : the journal of the American Medical Association, 302(10), 1084-1091. [19738093], [doi]  [abs]
  84. Wigal, SB; Kollins, SH; Childress, AC; Squires, L; 311 Study Group, (2009). A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.. Child and Adolescent Psychiatry and Mental Health, 3(1), 17. [19508731], [doi]  [abs]
  85. Kollins, SH; Garrett, ME; McClernon, FJ; Lachiewicz, AM; Morrissey-Kane, E; FitzGerald, D; Collins, AL; Anastopoulos, AD; Ashley-Koch, AE (2009). Effects of postnatal parental smoking on parent and teacher ratings of ADHD and oppositional symptoms.. Journal of Nervous and Mental Disease, 197(6), 442-449. [19525745], [doi]  [abs]
  86. Fuemmeler, BF; Agurs-Collins, T; McClernon, FJ; Kollins, SH; Garrett, ME; Ashley-Koch, AE (2009). Interactions between genotype and depressive symptoms on obesity.. Behavior Genetics, 39(3), 296-305. [19337825], [doi]  [abs]
  87. Kollins, SH; English, J; Robinson, R; Hallyburton, M; Chrisman, AK (2009). Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD).. Psychopharmacology, 204(1), 73-83. [19104775], [doi]  [abs]
  88. Willoughby, MT; Kollins, SH; McClernon, FJ; Family Life Investigative Group, (2009). Association between smoking and retrospectively reported attention-deficit/hyperactivity disorder symptoms in a large sample of new mothers.. Nicotine and Tobacco Research (OUP), 11(3), 313-322. [19307443], [doi]  [abs]
  89. Kollins, SH; McClernon, FJ; Epstein, JN (2009). Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis.. Drug and Alcohol Dependence, 100(1-2), 169-172. [19041198], [doi]  [abs]
  90. Kollins, SH; Anastopoulos, AD; Lachiewicz, AM; FitzGerald, D; Morrissey-Kane, E; Garrett, ME; Keatts, SL; Ashley-Koch, AE (2008). SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families.. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B(8), 1580-1588. [18821566], [doi]  [abs]
  91. Witt, KL; Shelby, MD; Itchon-Ramos, N; Faircloth, M; Kissling, GE; Chrisman, AK; Ravi, H; Murli, H; Mattison, DR; Kollins, SH (2008). Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD.. Journal of the American Academy of Child and Adolescent Psychiatry, 47(12), 1375-1383. [18978633], [doi]  [abs]
  92. McClernon, FJ; Kollins, SH (2008). ADHD and smoking: from genes to brain to behavior.. Annals of the New York Academy of Sciences, 1141, 131-147. [18991955], [doi]  [abs]
  93. Kollins, SH (2008). ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.. Journal of Attention Disorders, 12(2), 115-125. [18192623], [doi]  [abs]
  94. Adler, LA; Goodman, DW; Kollins, SH; Weisler, RH; Krishnan, S; Zhang, Y; Biederman, J; 303 Study Group, (2008). Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.. Journal of Clinical Psychiatry, 69(9), 1364-1373. [19012818]  [abs]
  95. Kollins, SH (2008). A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.. Current Medical Research and Opinion, 24(5), 1345-1357. [18384709], [doi]  [abs]
  96. McClernon, FJ; Kollins, SH; Lutz, AM; Fitzgerald, DP; Murray, DW; Redman, C; Rose, JE (2008). Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study.. Psychopharmacology, 197(1), 95-105. [18038223], [doi]  [abs]
  97. Fuemmeler, BF; Agurs-Collins, TD; McClernon, FJ; Kollins, SH; Kail, ME; Bergen, AW; Ashley-Koch, AE (2008). Genes implicated in serotonergic and dopaminergic functioning predict BMI categories.. Obesity (Silver Spring, Md.), 16(2), 348-355. [18239643], [doi]  [abs]
  98. McClernon, FJ; Fuemmeler, BF; Kollins, SH; Kail, ME; Ashley-Koch, AE (2008). Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults.. Nicotine and Tobacco Research (OUP), 10(1), 117-127. [18188752], [doi]  [abs]
  99. Laforett, DR; Murray, DW; Kollins, SH (2008). Psychosocial treatments for preschool-aged children with Attention-Deficit Hyperactivity Disorder.. Developmental Disabilities Research Review, 14(4), 300-310. [19072758], [doi]  [abs]
  100. Kollins, SH; March, JS (2007). Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.. Biological Psychiatry, 62(9), 951-953. [17950067], [doi]
  101. Fuemmeler, BF; Kollins, SH; McClernon, FJ (2007). Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood.. Journal of Pediatric Psychology, 32(10), 1203-1213. [17602186], [doi]  [abs]
  102. Ghuman, JK; Riddle, MA; Vitiello, B; Greenhill, LL; Chuang, SZ; Wigal, SB; Kollins, SH; Abikoff, HB; McCracken, JT; Kastelic, E; Scharko, AM; McGough, JJ; Murray, DW; Evans, L; Swanson, JM; Wigal, T; Posner, K; Cunningham, C; Davies, M; Skrobala, AM (2007). Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 563-580. [17979578], [doi]  [abs]
  103. Pettiford, J; Kozink, RV; Lutz, AM; Kollins, SH; Rose, JE; McClernon, FJ (2007). Increases in impulsivity following smoking abstinence are related to baseline nicotine intake and boredom susceptibility.. Addictive Behaviors, 32(10), 2351-2357. [17399907], [doi]  [abs]
  104. Swanson, JM; Moyzis, RK; McGough, JJ; McCracken, JT; Riddle, MA; Kollins, SH; Greenhill, LL; Abikoff, HB; Wigal, T; Wigal, SB; Posner, K; Skrobala, AM; Davies, M; Ghuman, JK; Cunningham, C; Vitiello, B; Stehli, A; Smalley, SL; Grady, D (2007). Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 635-646. [17979583], [doi]  [abs]
  105. Hardy, KK; Kollins, SH; Murray, DW; Riddle, MA; Greenhill, L; Cunningham, C; Abikoff, HB; McCracken, JT; Vitiello, B; Davies, M; McGough, JJ; Posner, K; Skrobala, AM; Swanson, JM; Wigal, T; Wigal, SB; Ghuman, JK; Chuang, SZ (2007). Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 621-634. [17979582], [doi]  [abs]
  106. Murray, DW; Kollins, SH; Hardy, KK; Abikoff, HB; Swanson, JM; Cunningham, C; Vitiello, B; Riddle, MA; Davies, M; Greenhill, LL; McCracken, JT; McGough, JJ; Posner, K; Skrobala, AM; Wigal, T; Wigal, SB; Ghuman, JK; Chuang, SZ (2007). Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 605-620. [17979581], [doi]  [abs]
  107. Vitiello, B; Abikoff, HB; Chuang, SZ; Kollins, SH; McCracken, JT; Riddle, MA; Swanson, JM; Wigal, T; McGough, JJ; Ghuman, JK; Wigal, SB; Skrobala, AM; Davies, M; Posner, K; Cunningham, C; Greenhill, LL (2007). Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 593-604. [17979580], [doi]  [abs]
  108. Abikoff, HB; Vitiello, B; Riddle, MA; Cunningham, C; Greenhill, LL; Swanson, JM; Chuang, SZ; Davies, M; Kastelic, E; Wigal, SB; Evans, L; Ghuman, JK; Kollins, SH; McCracken, JT; McGough, JJ; Murray, DW; Posner, K; Skrobala, AM; Wigal, T (2007). Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 581-592. [17979579], [doi]  [abs]
  109. Kratochvil, CJ; Vaughan, BS; Mayfield-Jorgensen, ML; March, JS; Kollins, SH; Murray, DW; Ravi, H; Greenhill, LL; Kotler, LA; Paykina, N; Biggins, P; Stoner, J (2007). A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.. Journal of Child and Adolescent Psychopharmacology, 17(2), 175-185. [17489712], [doi]  [abs]
  110. Posner, K; Melvin, GA; Murray, DW; Gugga, SS; Fisher, P; Skrobala, A; Cunningham, C; Vitiello, B; Abikoff, HB; Ghuman, JK; Kollins, S; Wigal, SB; Wigal, T; McCracken, JT; McGough, JJ; Kastelic, E; Boorady, R; Davies, M; Chuang, SZ; Swanson, JM; Riddle, MA; Greenhill, LL (2007). Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: The Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology, 17(5), 547-562. [doi]  [abs]
  111. Kollins, SH (2007). Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).. The American Journal on Addictions, 16 Suppl 1, 35-42. [17453605], [doi]  [abs]
  112. Levin, FR; Adamson, JJ; Antshel, KM; Biederman, J; Faraone, SV; Kollins, SH; Mariani, JJ; Monuteaux, MC; Petty, CR; Santry, AM; Sgambati, S; Spencer, TJ; Whitley, JS; Wilens, TE; Wilson, JJ (2007). ADHD and substance abuse update. The American Journal on Addictions, 16, 1-4. [Gateway.cgi], [doi]
  113. Epstein, JN; Kollins, SH (2006). Psychometric properties of an adult ADHD diagnostic interview.. Journal of Attention Disorders, 9(3), 504-514. [16481667], [doi]  [abs]
  114. McGough, J; McCracken, J; Swanson, J; Riddle, M; Kollins, S; Greenhill, L; Abikoff, H; Davies, M; Chuang, S; Wigal, T; Wigal, S; Posner, K; Skrobala, A; Kastelic, E; Ghuman, J; Cunningham, C; Shigawa, S; Moyzis, R; Vitiello, B (2006). Pharmacogenetics of methylphenidate response in preschoolers with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1314-1322. [doi]  [abs]
  115. Kollins, SH; Greenhill, L (2006). Evidence base for the use of stimulant medication in preschool children with ADHD. Infants and Young Children, 19(2), 132-141.  [abs]
  116. Kollins, S; Greenhill, L; Swanson, J; Wigal, S; Abikoff, H; McCracken, J; Riddle, M; McGough, J; Vitiello, B; Wigal, T; Skrobala, A; Posner, K; Ghuman, J; Davies, M; Cunningham, C; Bauzo, A (2006). Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1275-1283. [doi]  [abs]
  117. Wigal, T; Greenhill, L; Chuang, S; McGough, J; Vitiello, B; Skrobala, A; Swanson, J; Wigal, S; Abikoff, H; Kollins, S; McCracken, J; Riddle, M; Posner, K; Ghuman, J; Davies, M; Thorp, B; Stehli, A (2006). Safety and tolerability of methylphenidate in preschool children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1294-1303. [doi]  [abs]
  118. Greenhill, L; Kollins, S; Abikoff, H; McCracken, J; Riddle, M; Swanson, J; McGough, J; Wigal, S; Wigal, T; Vitiello, B; Skrobala, A; Posner, K; Ghuman, J; Cunningham, C; Davies, M; Chuang, S; Cooper, T (2006). Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1284-1293. [doi]  [abs]
  119. Swanson, J; Greenhill, L; Wigal, T; Kollins, S; Stehli, A; Davies, M; Chuang, S; Vitiello, B; Skrobala, A; Posner, K; Abikoff, H; Oatis, M; McCracken, J; McGough, J; Riddle, M; Ghuman, J; Cunningham, C; Wigal, S (2006). Stimulant-related reductions of growth rates in the PATS. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1304-1313. [doi]  [abs]
  120. Preston, RJ; Kollins, SH; Swanson, JM; Greenhill, LL; Wigal, T; Elliott, GR; Vitiello, B (2005). Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.. Cancer Letters, 230(2), 292-294. [16019134], [doi]
  121. MacDonald Fredericks, E; Kollins, SH (2005). A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder.. Journal of Child and Adolescent Psychopharmacology, 15(5), 729-741. [16262590], [doi]  [abs]
  122. Kollins, SH; McClernon, FJ; Fuemmeler, BF (2005). Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults.. Archives of General Psychiatry, 62(10), 1142-1147. [16203959], [doi]  [abs]
  123. Wigal, SB; McGough, JJ; McCracken, JT; Biederman, J; Spencer, TJ; Posner, KL; Wigal, TL; Kollins, SH; Clark, TM; Mays, DA; Zhang, Y; Tulloch, SJ (2005). A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.. Journal of Attention Disorders, 9(1), 275-289. [16371674], [doi]  [abs]
  124. Fredericks, EM; Kollins, SH (2004). Assessing methylphenidate preference in ADHD patients using a choice procedure.. Psychopharmacology, 175(4), 391-398. [15258716], [doi]  [abs]
  125. Swanson, JM; Wigal, SB; Wigal, T; Sonuga-Barke, E; Greenhill, LL; Biederman, J; Kollins, S; Nguyen, AS; DeCory, HH; Dirksen, SJH; Hatch, SJ (2004). A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).. Pediatrics, 113(3 Pt 1), e206-e216.  [abs]
  126. Kollins, SH (2003). Delay discounting is associated with substance use in college students.. Addictive Behaviors, 28(6), 1167-1173. [12834659]  [abs]
  127. Kollins, SH (2003). Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.. Journal of Clinical Psychiatry, 64 Suppl 11, 14-18. [14529325]  [abs]
  128. Kollins, SH; Rush, CR (2002). Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans.. Biological Psychiatry, 51(2), 143-150. [11822993]  [abs]
  129. Kollins, SH; MacDonald, EK; Rush, CR (2001). Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review.. Pharmacology Biochemistry and Behavior, 68(3), 611-627. [11325419]  [abs]
  130. Kollins, SH; Barkley, RA; DuPaul, GJ (2001). Use and management of medications for children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Focus on Exceptional Children, 33(5), X-24.
  131. Kollins, SH; Barkley, RA; DuPaul, GJ (2001). Use and management of medications for children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Focus on Exceptional Children, 33(5), X-24.
  132. Critchfield, TS; Kollins, SH (2001). Temporal discounting: basic research and the analysis of socially important behavior.. Journal of Applied Behavior Analysis, 34(1), 101-122. [11317983], [doi]  [abs]
  133. Critchfield, TS; Newland, MC; Kollins, SH (2000). The good, the bad, and the aggregate.. The Behavior analyst / MABA, 23(1), 107-115. [22478342]  [abs]
  134. Murray, LK; Kollins, SH (2000). Effects of methylphenidate on sensitivity to reinforcement in children diagnosed with attention deficit hyperactivity disorder: an application of the matching law.. Journal of Applied Behavior Analysis, 33(4), 573-591. [11214032], [doi]  [abs]
  135. Kollins, SH; Rush, CR (1999). Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.. Pharmacology Biochemistry and Behavior, 64(2), 319-326. [10515308]  [abs]
  136. Daleiden, EL; Chorpita, BF; Kollins, SH; Drabman, RS (1999). Factors affecting the reliability of clinical judgments about the function of children's school-refusal behavior.. Journal of Clinical Child and Adolescent Psychology, 28(3), 396-406. [10446689], [doi]  [abs]
  137. Phillips, EL; Kollins, S; Edgerly, D (1999). Behavioural assessment of children and adolescents. Indian Journal of Pediatrics, 66(3), 389-399.  [abs]
  138. Forsyth, JP; Kollins, S; Palav, A; Duff, K; Maher, S (1999). Has behavior therapy drifted from its experimental roots? A survey of publication trends in mainstream behavioral journals. Journal of Behavior Therapy and Experimental Psychiatry, 30(3), 205-220. [doi]  [abs]
  139. Kollins, SH; Newland, MC; Critchfield, TS (1999). Quantitative integration of single-subject studies: Methods and misinterpretations.. The Behavior analyst / MABA, 22(2), 149-157. [22478332]  [abs]
  140. Kollins, SH; Rush, CR; Pazzaglia, PJ; Ali, JA (1998). Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.. Experimental and Clinical Psychopharmacology, 6(4), 367-374. [9861551]  [abs]
  141. Kollins, SH; Shapiro, SK; Newland, MC; Abramowitz, A (1998). Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).. Experimental and Clinical Psychopharmacology, 6(4), 375-389. [9861552]  [abs]
  142. Rush, CR; Kollins, SH; Pazzaglia, PJ (1998). Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.. Experimental and Clinical Psychopharmacology, 6(1), 32-44. [9526144]  [abs]
  143. Kollins, SH; Newland, MC; Critchfield, TS (1997). How much do consequences matter? (vol 4, pg 208, 1997). Psychonomic Bulletin and Review, 4(3), 431-431. [Gateway.cgi], [doi]
  144. Kollins, SH; Newland, MC; Critchfield, TS (1997). Human sensitivity to reinforcement in operant choice: How much do consequences matter?. Psychonomic Bulletin and Review, 4(2), 208-220. [21331827], [doi]  [abs]
  145. Kollins, SH; Lane, SD; Shapiro, SK (1997). Experimental analysis of childhood psychopathology: A laboratory matching analysis of the behavior of children diagnosed with Attention-Deficit Hyperactivity Disorder (ADHD). Psychological Record, 47(1), 25-44.  [abs]

Chapters in Books

  1. Murphy, SK; Schrott, R; Visco, Z; Huang, Z; Grenier, C; Mitchell, J; Schechter, J; Lucas, J; Levin, ED; Price, T; Kollins, SH "Environment and Gametic Epigenetic Reprogramming.."  September, 2017: S28-S28.
  2. Kollins, SH; McClernon, FJ "ADHD and smoking." Attention-Deficit Hyperactivity Disorder in Adults and Children. January, 2015: 327-342. [doi]  [abs]
  3. McClernon, FJ; Mitchell, JT; Schick, RS; Bayham, RL; Dennis, ME; Kollins, SH; Beckham, JC "COMBINED EMA AND GPS FOR ASSESSING THE SPATIAL DISTRIBUTION OF SMOKING BEHAVIOR: A PROOF OF CONCEPT STUDY."  March, 2013: S93-S93.
  4. Mitchell, JT; Kollins, SH "Attention-deficit/hyperactivity disorder in adolescence." Handbook of Adolescent Health Psychology. January, 2013: 423-445. [doi]
  5. Mitchell, JT; Kollins, SH "ADHD in adolescence." Adolescent health psychology. Ed. O'Donohue, W; Benuto, L; Tolle, L SPRINGER, 2013: 423-445.
  6. Bidwell, LC; Garrett, ME; McClernon, FJ; Fuemmeler, BF; Williams, RB; Ashley-Koch, AE; Kollins, SH "Genotype and ADHD symptoms interact to predict adolescents' early smoking experiences in an epidemiological sample."  November, 2011: 893-893. [Gateway.cgi]
  7. Kollins, SH "Abuse potential of stimulant drugs used to treat ADHD." ADHD in Adults: Characterization, Diagnosis, and Treatment. January, 2011: 230-239. [doi]  [abs]
  8. Witt, KL; Shelby, MD; Itchon-Ramos, N; Faircloth, M; Kissling, GE; Chrisman, AK; Ravi, H; Murli, H; Mattison, DR; Kollins, SH "Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of pediatric ADHD patients treated with stimulant drugs."  August, 2008: 528-528. [Gateway.cgi]
  9. Goodman, D; Adler, L; Kollins, SH; Weisler, R; Krishnan, S; Zhang, Y; Biederman, J "Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder."  July, 2008: 292-293. [Gateway.cgi]
  10. Kollins, SH; Wigal, T; Vince, B; Lyne, A; Farrand, K "Cognitive and sedative effects of guanfacine extended release in children and adolescents aged 6 to 17 years with attention-deficit/hyperactivity disorder: Safety and sleep effects."  April, 2008: 246S-246S. [Gateway.cgi]

Duke University * Arts & Sciences * Faculty * Staff * Grad * Postdocs * Reload * Login